Why the study?
Does percutaneous left ventricular assist device (pLVAD) support improve clinical outcomes in patients undergoing ablation of ventricular tachycardia?
Does percutaneous left ventricular assist device (pLVAD) support improve clinical outcomes in patients undergoing ablation of ventricular tachycardia?
Meta-analysis of observational data suggests pLVAD support during VT ablation does not provide clinical benefit and is associated with longer procedure times and more complications.
This meta-analysis did not show clinical benefits from using pLVAD support during VT ablation, whereas it was associated with longer procedure times and more complications. This study was, however, limited by the observational nature of the data. In view of these data, the risk and benefit of pLVAD support during VT ablation should be considered on an individual basis.
No takes yet. Share an insight, caveat, or question.
Luni et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: